Prequalification Update - 25 November 2009

WHO Prequalification Programme publishes new WHO Public Assessment Reports (WHOPARs)

     The WHOPARs cover the following products:

• IN003:   Oseltamivir (as phosphate) - 12mg/ml - Powder for oral suspension - Roche Ltd - SWITZERLAND
  
  
• IN004:   Oseltamivir (as phosphate) - 30mg - Capsules - Roche Ltd - SWITZERLAND
  
  
• IN005:   Oseltamivir (as phosphate) - 45mg - Capsules - Roche Ltd - SWITZERLAND
  
  
• IN006:   Oseltamivir (as phosphate) - 75mg - Capsules - Roche Ltd - SWITZERLAND
  
  
• IN007:   Zanamivir - 5mg/dose - Inhalation powder - GlaxoSmithKline Ltd - UNITED KINGDOM

Related Link:  Overview of WHOPARs of Prequalified Medicinal Products